Fig 1: The effect of arctigenin on the ratio of EPO/EPOR in the cerebral ischemia-reperfusion model rats (bar = 50 µm). Compared to the sham group, ##P<0.01; compared to the model group, **P < 0.01; compared to the EPO antibody group, △△P < 0.01.
Fig 2: The effect of arctigenin on the protein expression of EPO, EPOR, HIF-1, JAK2, STAT5, and NF-κB in the cerebral ischemia-reperfusion model rats at 72 h post-reperfusion. Compared to the sham group, ##p < 0.01; compared to the model group, **p < 0.01; compared to the EPO antibody group, △△p < 0.01. (A) Control group; (B) Sham group; (C) Model group; (D) EPO antibody group; (E) Arctigenin group.
Supplier Page from Abcam for Anti-EPO-R antibody [EPR22366-40]